Jeff Eidel is a seasoned genomics executive with a robust background in corporate development and finance. They served as Corporate Controller at Inovio Pharmaceuticals Inc. from 2004 to 2006 and held various senior roles at Illumina, culminating as Head of Corporate & Business Development in 2019. In 2022, Jeff became the Chief Executive Officer of Cradle Genomics and later served as Chief Commercial Officer at PacBio until 2024. Currently, they are the SVP of Operations and Corporate & Business Development at Cellanome. Jeff earned a BA in Finance & Accounting from The University of Montana's College of Business in 1998.
This person is not in the org chart
This person is not in any teams
This person is not in any offices